Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorValente, Giulia M-
dc.contributor.authorAmor, David J-
dc.contributor.authorIoannou, Liane J-
dc.contributor.authorArchibald, Alison D-
dc.identifier.citationThe Australian & New Zealand Journal of Obstetrics & Gynaecology 2021; 61(2): 232-238en
dc.description.abstractCystic fibrosis (CF) carrier screening should be offered to people planning a pregnancy or in early pregnancy, according to current recommendations. However, research indicates rates of offering CF carrier screening are low. Health professionals (HPs) play an important role in offering population carrier screening. To determine the opinions, knowledge and practice patterns of HPs with regard to the routine offering of population carrier screening for CF. Five key informant interviews informed the development of an online questionnaire which was distributed to a select group of HPs involved in prenatal care in Victoria, Australia. Of the participants who completed the questionnaire (n = 87), 35.6% reported offering CF carrier screening to all patients attending for preconception or early pregnancy consultations. High referrers of CF carrier screening were more likely to be female, work in the private sector, in metropolitan areas and specialise as an obstetrician. High referrers demonstrated a greater level of knowledge of CF and carrier screening than low referrers (t = -3.779, P < 0.001). Low referrers perceived more barriers to offering carrier screening than high referrers (t = 2.125, P = 0.037). Low referrers were more likely to perceive lack of community awareness and HP knowledge as a barrier to offering CF carrier screening, compared to high referrers, who were more likely to perceive time constraints as a barrier. To promote routine offering of population CF carrier screening, resources are needed to improve knowledge and provide clinical support thereby reducing perceived barriers.en
dc.subjectcystic fibrosisen
dc.subjectgenetic carrier screeningen
dc.subjecthealth knowledgeen
dc.subjectpractice patternsen
dc.titleFactors influencing medical practitioner participation in population carrier screening for cystic fibrosis.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Australian & New Zealand Journal of Obstetrics & Gynaecologyen
dc.identifier.affiliationVictorian Clinical Genetics Services, Melbourne, Victoria, Australiaen
dc.identifier.affiliationMurdoch Children's Research Institute, Melbourne, Victoria, Australiaen
dc.identifier.affiliationPublic Health & Preventive Medicine, Monash University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationClinical Geneticsen
dc.identifier.pubmedid33135161-, Giulia M
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.languageiso639-1en- Genetics-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Sep 21, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.